Speed 'Training' Prepares Bacteria for Complex Tasks, Like Munching Plastics

Why It Matters

LySE dramatically shortens the time needed to engineer microbes that can break down plastics and other pollutants, unlocking scalable bioremediation and synthetic‑biology applications. Its ability to evolve whole pathways without off‑target mutations lowers development risk for industrial biotech firms.

Key Takeaways

• LySE evolves up to 40 kb gene clusters, five times larger than PACE.
• Five‑gene ethylene‑glycol pathway improved 50 % biomass after five cycles.
• Error‑prone T7 polymerase adds 160 000‑fold higher mutation rate.
• Platform switches mutation and selection phases by adjusting phage‑bacteria ratio.
• Optimized pathways transfer to new hosts without unwanted genome‑wide mutations.

Pulse Analysis

Plastic pollution remains a global crisis, prompting scientists to turn to engineered microbes as a sustainable solution. Traditional approaches to redesign bacterial metabolism involve painstaking, step‑by‑step gene edits that can take months or years, especially when multiple enzymes must work in concert. The challenge is compounded by the need to preserve overall cellular health while introducing new pathways, a balance that has limited the commercial rollout of plastic‑degrading strains.

LySE tackles these hurdles by marrying the speed of continuous evolution with the precision of discrete selection. By harnessing a modified T7 bacteriophage, the platform injects a hyper‑mutagenic DNA polymerase that creates a flood of mutations across a targeted 40‑kilobase gene cluster. Researchers then pause the process, introduce the mutated cluster into fresh bacteria, and select for improved growth on the target substrate. This toggleable workflow eliminates the “cheater” problem seen in earlier phage‑assisted methods and allows rapid, iterative refinement of entire metabolic routes rather than single enzymes.

The broader impact reaches beyond plastic digestion. Pharmaceutical firms can accelerate the optimization of biosynthetic pathways for high‑value drugs, while environmental biotech companies can fine‑tune microbes that degrade oil spills, pesticides, or emerging contaminants. Moreover, LySE’s compatibility with AI‑designed synthetic pathways opens a pathway for turning computational enzyme designs into functional, industrial‑scale biocatalysts. As the platform moves toward commercial licensing, it could become a cornerstone technology for the next generation of sustainable manufacturing and waste‑to‑value solutions.